Arrowstreet Capital Limited Partnership increased its position in shares of Waters Co. (NYSE:WAT) by 8.8% during the 4th quarter, Holdings Channel reports. The fund owned 556,465 shares of the medical instruments supplier’s stock after buying an additional 44,897 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Waters were worth $107,503,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Advisory Services Network LLC boosted its stake in Waters by 6.0% during the 2nd quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after acquiring an additional 65 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its stake in Waters by 3.0% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 6,668 shares of the medical instruments supplier’s stock valued at $1,226,000 after buying an additional 196 shares in the last quarter. Advisor Partners LLC lifted its stake in Waters by 11.6% in the fourth quarter. Advisor Partners LLC now owns 2,372 shares of the medical instruments supplier’s stock valued at $500,000 after buying an additional 246 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in Waters by 0.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 46,545 shares of the medical instruments supplier’s stock valued at $8,992,000 after buying an additional 253 shares in the last quarter. Finally, LS Investment Advisors LLC lifted its stake in Waters by 7.0% in the fourth quarter. LS Investment Advisors LLC now owns 3,962 shares of the medical instruments supplier’s stock valued at $765,000 after buying an additional 259 shares in the last quarter. 93.36% of the stock is currently owned by institutional investors and hedge funds.
Shares of Waters Co. (WAT) opened at $206.18 on Tuesday. The company has a quick ratio of 1.97, a current ratio of 2.10 and a debt-to-equity ratio of 0.66. Waters Co. has a fifty-two week low of $152.05 and a fifty-two week high of $220.20. The stock has a market cap of $16,400.00, a P/E ratio of 1,145.44, a PEG ratio of 2.47 and a beta of 0.88.
In other news, Director William J. Miller sold 3,500 shares of Waters stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total value of $682,290.00. Following the sale, the director now directly owns 25,849 shares in the company, valued at $5,039,004.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark T. Beaudouin sold 42,143 shares of Waters stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total transaction of $9,153,881.03. Following the completion of the sale, the senior vice president now owns 20,749 shares in the company, valued at $4,506,890.29. The disclosure for this sale can be found here. Insiders sold 121,289 shares of company stock worth $25,383,542 over the last quarter. 5.07% of the stock is owned by corporate insiders.
WAT has been the topic of a number of research reports. BTIG Research initiated coverage on shares of Waters in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 price target on the stock. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $217.00 price target on the stock in a research note on Tuesday, December 26th. Janney Montgomery Scott lifted their price target on shares of Waters from $200.00 to $230.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Barclays lifted their price target on shares of Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Finally, Morgan Stanley raised shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target on the stock in a research note on Monday, December 4th. Twelve research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $203.75.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2018/02/20/waters-co-wat-position-lifted-by-arrowstreet-capital-limited-partnership.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.